
RadNet partners with Desert Oasis Healthcare to provide AI-enhanced breast cancer detection at no extra cost.
Key Details
- 1RadNet partners with Desert Oasis Healthcare to deploy Enhanced Breast Cancer Detection (EBCD) program.
- 2EBCD utilizes AI to identify suspicious breast areas possibly missed by radiologists.
- 3The program is now offered to Desert Oasis patients without extra fees; previously, there was up to a $60 out-of-pocket charge since its 2022 launch.
- 4AI-based EBCD users are 21% more likely to have breast cancer detected, per recent research.
Why It Matters

Source
Radiology Business
Related News

AI-Based Slab Reconstruction Streamlines Digital Breast Tomosynthesis
AI-driven slab reconstruction in DBT improves workflow efficiency without compromising diagnostic accuracy in breast cancer screening.

AI Advances in Breast Cancer Risk, CEUS Training Updates, and Imaging AI Variability
This week's top radiology news reviews AI advances in breast and lung cancer risk prediction, new CEUS training standards, and prostate screening updates with imaging modalities.

DeepHealth's Prostate AI Gains FDA Clearance for MRI Workflows
DeepHealth, a RadNet subsidiary, received FDA clearance for its AI solution to assist prostate cancer detection and MRI workflow.